Neurorx, Inc
NRx Pharmaceuticals, formerly known as NeuroRx, Inc., is a clinical-stage biopharmaceutical company located in Wilmington, Delaware, focused on developing therapeutics for central nervous system disorders, particularly suicidal depression and post-traumatic stress disorder (PTSD). The company is advancing its lead program, NRX101, an oral fixed-dose combination therapy targeting the brain's NMDA receptor.
NRx Pharmaceuticals has filed an Abbreviated New Drug Application for NRX100, a preservative-free intravenous ketamine formulation, to address the needs of patients with suicidal depression. The company is also expanding its reach through strategic acquisitions, providing a range of precision psychiatry services across multiple locations in Florida.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.